Skip to main navigation Skip to search Skip to main content

Abstract

Dyslipidaemia is a modifiable cause of increased mortality in patients with mental illness. We described prevalence, aetiology and treatment of dyslipidaemia in patients with mental illness. Patients with mental illness have a higher prevalence of dyslipidaemia than the general population due to genetic predisposition, unhealthy lifestyle and/or psychotropic medications. Attention towards early identification of dyslipidaemia, close monitoring, and a low threshold for initiating treatment with lifestyle interventions and lipid-lowering agents are warranted in patients with mental illness.

Original languageEnglish
JournalUgeskrift for Laeger
Volume184
Issue number10
ISSN0041-5782
Publication statusPublished - 7 Mar 2022

Fingerprint

Dive into the research topics of 'Dyslipidaemia in patients with mental illness'. Together they form a unique fingerprint.

Cite this